Evaluation of early retinal changes in patients on long-term hydroxychloroquine using optical coherence tomography angiography
Huanhuan Zhao,Menglu Pan,Yaping Liu,Fangyue Cheng,Zongwen Shuai
DOI: https://doi.org/10.1177/20420986231225851
2024-01-29
Therapeutic Advances in Drug Safety
Abstract:Therapeutic Advances in Drug Safety, Volume 15, Issue , January-December 2024. Background:Connective tissue diseases (CTD), including systemic lupus erythematosus and rheumatoid arthritis (RA), have long been treated with hydroxychloroquine (HCQ). However, prolonged HCQ use poses a risk of adverse effects, particularly retinopathy.Objective:To detect early retinal changes assessed by optical coherence tomography angiography (OCTA) in CTD patients with long-term HCQ treatment and to explore the relationship between OCTA parameters and the concentrations of HCQ and its metabolites.Design:A cross-sectional study conducted from March 2020 to October 2021 at the First Affiliated Hospital of Anhui Medical University.Methods:The area and perimeter of the foveal avascular zone (FAZ), the thickness of the fovea and parafovea, and the vascular density of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) in each area of the macula were measured by OCTA in 43 CTD patients treated with HCQ for over 6 months. Meantime, blood concentrations of HCQ and its metabolites were determined by high-performance liquid chromatography-tandem mass spectrometry, and the clinical documents of all 43 involved patients were collected.Results:There is no significant correlation between OCTA outcomes and the patient's age, disease duration, and weight-dependent dose. HCQ cumulative duration positively correlated with FAZ area and perimeter (r = 0.419, p = 0.005 and r = 0.407, p = 0.007, respectively) and negatively correlated with the foveal vessel density in DCP (r = −0.378, p = 0.012). HCQ cumulative dose had a positive correlation with FAZ area and perimeter (r = 0.445, p = 0.003 and r = 0.434, p = 0.004, respectively) and had a negative correlation with foveal vessel density in SCP and DCP (r = −0.383, p = 0.011 and r = −0.424, p = 0.005, respectively). OCTA outcomes did not correlate with HCQ and its metabolite concentrations.Conclusion:OCTA could be used to detect microvascular changes in the macula of CTD patients with long-term HCQ therapy. It was not found the concentrations of HCQ and its metabolites were associated with retinal vascular changes.Plain language summaryRetinal microvascular changes were assessed in connective tissue disease patients treated with hydroxychloroquineIntroduction:Long-term use of hydroxychloroquine (HCQ) may affect the eyes. In this study, we aimed to identify early eye changes in people with connective tissue diseases (CTD) who have been using HCQ for an extended period. Additionally, we wanted to explore the relationship between these changes and the amount of HCQ and its byproducts in their bodies.Methods:Between March 2020 and October 2021, we enrolled 43 patients with CTD who had been taking HCQ for more than 6 months. We collected various clinical information, including gender, age, diagnosis, disease duration, HCQ dosage, and treatment duration. We used specialized imaging called optical coherence tomography angiography (OCTA) to detect early microvascular changes in the macula and employed high-performance liquid chromatography-tandem mass spectrometry to measure HCQ and its metabolites in the blood. We also analyzed the relationships between these outcomes.Results:Our study did not reveal significant associations between OCTA results and patients' age, disease duration, or HCQ dosage based on their weight. However, we found that as the duration of HCQ use increased, the size (area and perimeter) of the foveal avascular zone (FAZ) in the eye grew larger. Additionally, in individuals who had used HCQ for an extended period, the density of blood vessels in the back of the eye was lower in the foveal area. Importantly, OCTA parameters did not correlate with the blood concentrations of HCQ and its metabolites.Conclusions:Our use of OCTA detected subtle changes in the blood vessels at the center of the eye in people with CTD who had been using HCQ for an extended period. Notably, these OCTA parameters did not show any connection with the blood concentrations of HCQ and its metabolites.
pharmacology & pharmacy